|When compared with bupivicaine HCl for pain management following total knee arthroplasty, periarticular injection of liposomal bupivicaine offers which of the following?|
- Lower visual analog scale (VAS) in-hospital pain scores There is no data to suggest lower pain scores in high quality studies.
- Improved Knee Society scores at 6 weeks There is no data to suggest improved functional outcomes.
- Reduced opioid consumption There is no data to suggest reduced opioid consumption.
- No difference in pain control, function, or opioid consumption Several randomized controlled trials have found no benefit to liposomal bupivicaine.